MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Bay City Capital
Finance & Acquisition: Bay City
*Portfolio Companies: Bay City
Phenomix
Parents
*Architects: Diabetes, Metabolic Disease, Dialysis, Renal & Kidney Companies (Pharmaceuticals, Biotechnology, Biosimilars)
*Industry: San Diego, California
*Portfolio Companies: Bay City
WatchList: Closing, Closed, Inactive, Liquidation, Dissolution or Out of Business
Children
Inhibit therapeutic targets in the protease and kinase families.
Phenomix has a portfolio of programs underway in multiple indications.
Phenomix, Forest Labs Ink $340M Deal (2008)
Phenomix, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Labs Walks
San Diego, California
The most advanced programs are a Phase II inhibitor of the protease DPP4 for treatment of type 2 diabetes and a preclinical prog